Literature DB >> 21381028

Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys.

Jan Willem Leeuwis1, Tri Q Nguyen, Susana M Chuva de Sousa Lopes, Dionne M van der Giezen, Kevin van der Ven, Peter J H Rouw, G Johan A Offerhaus, Christine L Mummery, Roel Goldschmeding.   

Abstract

Bone morphogenetic protein 7 (BMP7) is a key determinant of renal response to injury, exhibiting strong protective as well as regenerative potential in a variety of experimental models. In vitro, beneficial effects of stimulation with BMP7 and other BMPs have been observed in many renal cell types. Still, it remains poorly understood which cells in the native kidney actually respond to BMPs in health and disease. Here, we report the use of BRE:gfp mice expressing green fluorescent protein (GFP) under the control of a pSmad1/5/8-specific BMP-responsive element (BRE) to directly visualize the spatiotemporal distribution of transcriptional activity downstream of canonical BMP signalling in healthy kidneys and in two distinct models of kidney disease. BRE-GFP signal coincided with expression of endogenous BMP target genes but, surprisingly, it was much more restricted than expected from the widespread distribution of pSmad1/5/8, a classical component of canonical BMP signal tranduction. BRE-GFP was mainly present in podocytes and collecting duct cells, and both glomerular and medullary BRE-GFP decreased following ischaemia-reperfusion injury as well as following unilateral ureteric obstruction, together with decreased BMP7, pSmad1/5/8 and BMP target gene expression. Remarkably, however, BRE-GFP was increased in injured proximal tubules in association with up-regulation of BMP receptors ALK2 and ALK3. Thus, native BMP transcriptional activity is much more restricted than previously suggested based on pSmad1/5/8 detection alone, and its response to injury varies according to cell type and nephron segment.
Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21381028     DOI: 10.1002/path.2844

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

1.  Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.

Authors:  Yoshiko Matsumoto; Akiyasu Kanamori; Makoto Nakamura; Akira Negi
Journal:  Jpn J Ophthalmol       Date:  2014-03-11       Impact factor: 2.447

2.  Increased Tbx1 expression may play a role via TGFβ-Smad2/3 signaling pathway in acute kidney injury induced by gentamicin.

Authors:  Hongkun Jiang; Lei Li; Jesse Li-Ling; Guangrong Qiu; Zhibin Niu; Hong Jiang; Yunpeng Li; Yaoguo Huang; Kailai Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

3.  Insulin receptor substrate-2 is expressed in kidney epithelium and up-regulated in diabetic nephropathy.

Authors:  Michelle B Hookham; Helen C O'Donovan; Rachel H Church; Annie Mercier-Zuber; Lucilla Luzi; Simon P Curran; Rosemarie M Carew; Alejandra Droguett; Sergio Mezzano; Markus Schubert; Morris F White; John K Crean; Derek P Brazil
Journal:  FEBS J       Date:  2013-05-29       Impact factor: 5.542

4.  Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome.

Authors:  Daniela A Braun; Carolin E Sadowski; Stefan Kohl; Svjetlana Lovric; Susanne A Astrinidis; Werner L Pabst; Heon Yung Gee; Shazia Ashraf; Jennifer A Lawson; Shirlee Shril; Merlin Airik; Weizhen Tan; David Schapiro; Jia Rao; Won-Il Choi; Tobias Hermle; Markus J Kemper; Martin Pohl; Fatih Ozaltin; Martin Konrad; Radovan Bogdanovic; Rainer Büscher; Udo Helmchen; Erkin Serdaroglu; Richard P Lifton; Wolfram Antonin; Friedhelm Hildebrandt
Journal:  Nat Genet       Date:  2016-02-15       Impact factor: 38.330

5.  BMP-SMAD signalling output is highly regionalized in cardiovascular and lymphatic endothelial networks.

Authors:  Karen Beets; Michael W Staring; Nathan Criem; Elke Maas; Niels Schellinx; Susana M Chuva de Sousa Lopes; Lieve Umans; An Zwijsen
Journal:  BMC Dev Biol       Date:  2016-10-10       Impact factor: 1.978

6.  CCN2 reduction mediates protective effects of BMP7 treatment in obstructive nephropathy.

Authors:  Lucas L Falke; Jan Willem Leeuwis; Karen M Lyons; Christine L Mummery; Tri Q Nguyen; Roel Goldschmeding
Journal:  J Cell Commun Signal       Date:  2016-10-20       Impact factor: 5.782

Review 7.  The BMP Pathway in Blood Vessel and Lymphatic Vessel Biology.

Authors:  Ljuba C Ponomarev; Jakub Ksiazkiewicz; Michael W Staring; Aernout Luttun; An Zwijsen
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

8.  Activation of the canonical bone morphogenetic protein (BMP) pathway during lung morphogenesis and adult lung tissue repair.

Authors:  Alexandros Sountoulidis; Athanasios Stavropoulos; Stavros Giaglis; Eirini Apostolou; Rui Monteiro; Susana M Chuva de Sousa Lopes; Huaiyong Chen; Barry R Stripp; Christine Mummery; Evangelos Andreakos; Paschalis Sideras
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

9.  Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury.

Authors:  Sachiko Yamada; Jin Nakamura; Misako Asada; Masayuki Takase; Taiji Matsusaka; Taku Iguchi; Ryo Yamada; Mari Tanaka; Atsuko Y Higashi; Tomohiko Okuda; Nariaki Asada; Atsushi Fukatsu; Hiroshi Kawachi; Daniel Graf; Eri Muso; Toru Kita; Takeshi Kimura; Ira Pastan; Aris N Economides; Motoko Yanagita
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  Defining the short-term effects of pharmacological 5'-AMP activated kinase modulators on mitochondrial polarization, morphology and heterogeneity.

Authors:  Mohamed Kodiha; Etienne Flamant; Yi Meng Wang; Ursula Stochaj
Journal:  PeerJ       Date:  2018-08-30       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.